Liu Mingzhu, Geng Jiawei, Liu Tao, Liu Xiaoli
Ophthalmologic Center of the Second Hospital, Jilin University, Changchun, China.
Front Immunol. 2025 Jul 29;16:1614304. doi: 10.3389/fimmu.2025.1614304. eCollection 2025.
Noninfectious uveitis (NIU) is a vision-threatening autoimmune disease of the eye, but its pathogenesis is still not fully understood. Recently, accumulating evidence suggests that gut microbiome dysbiosis may affect the development and progression of NIU through potential mechanisms, including translocation, molecular mimicry, and bystander activation. Understanding the mechanisms of gut microbiome-host interactions, especially the gut-eye axis regulation, can offer a theoretical foundation for developing novel therapeutic strategies. We summarized current evidence on the dysregulation of gut microbiome and metabolites in NIU, and explored potential mechanisms involved. Furthermore, possible therapeutic measures are discussed, including probiotics, prebiotics, dietary modifications, antibiotic interventions, as well as fecal microbial transplantation, aiming to exert beneficial effects on NIU progression by reshaping the gut microbial composition.
非感染性葡萄膜炎(NIU)是一种威胁视力的眼部自身免疫性疾病,但其发病机制仍未完全明确。最近,越来越多的证据表明,肠道微生物群失调可能通过潜在机制影响NIU的发生和发展,这些机制包括易位、分子模拟和旁观者激活。了解肠道微生物群与宿主相互作用的机制,尤其是肠-眼轴调节,可为开发新的治疗策略提供理论基础。我们总结了目前关于NIU中肠道微生物群和代谢产物失调的证据,并探讨了其中涉及的潜在机制。此外,还讨论了可能的治疗措施,包括益生菌、益生元、饮食调整、抗生素干预以及粪便微生物移植,旨在通过重塑肠道微生物组成对NIU的进展产生有益影响。